CureDuchenne was founded in 2003 with a focus on saving the lives of those with Duchenne muscular dystrophy, a disease that affects more than 300,000 boys worldwide. With support from CureDuchenne, three pharmaceutical treatments could be approved by...Show all
Phone: 949-872-2552
1400 Quail Street
Newport Beach, 92660-2730
California, United States
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2016-01-06 | RASRx | Corporate Minority | ||
2006-01-06 | Prosensa | Seed VC | $3.91M | Aktion Benni, Association Francaise contre les Myopathies, Charleys Fund, MedSciences Capital Management, and SenterNovem |